Search - tctmd.com

Displaying 161 - 180 of 334

Sort: Relevancy | Date

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

Presentation TCT 2016

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi

November 02, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner

November 01, 2016

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Robert-Jan van Geuns

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber

November 01, 2016

Presentation TCT 2016

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Presenter: Ron Waksman, Robert-Jan van Geuns, Michael Haude

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Inspiron

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Micell

Presenter: Alexandre Abizaid, Ashok Seth, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Firehawk

Presenter: Alexandre Abizaid, Ashok Seth, Runlin Gao

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Desyne BD

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Biomime

Presenter: Alexandre Abizaid, Ashok Seth

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Alex

Presenter: Alexandre Abizaid, Ashok Seth, Dariusz Dudek

October 31, 2016

Presentation TCT 2016

Device and Clinical Program Highlights: Abluminus

Presenter: Alexandre Abizaid, Ashok Seth, Dinesh Shah

October 31, 2016

Presentation TCT 2016

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More

Presenter: Koen Deloose, Jihad A. Mustapha

October 30, 2016

Advertisement

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Highlights (and my Interpretations) From: New BRS - FANTOM II, MeRes-1, FORTITUDE and FUTURE-I (6-9 Month Results)

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Device Specifications and Clinical Program Update: Inspiron

Device Specifications and Clinical Program Update: Micell

Device Specifications and Clinical Program Update: Firehawk

Device Specifications and Clinical Program Update: Desyne BD

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Device Specifications and Clinical Program Update: Biomime

Device Specifications and Clinical Program Update: Alex

Device and Clinical Program Highlights: Abluminus

Choosing Between Coronary DES, Self-Expanding Stents, Bioresorbable Scaffolds, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content